Table 7 Characteristics of invasive cancers
From: Introduction of organised mammography screening in tyrol: results of a one-year pilot phase
40-49 | 50-59 | 60-69 | Total | |
|---|---|---|---|---|
Tumour size (mm): | 13.5; 3-50 | 14; 2-60 | 12; 1-49 | 13; 1-60 |
Median; range | ||||
Tumour size (mm): | ||||
<= 10 mm | 6 (42.9%) | 6 (30.0%) | 10 (37.0%) | 21 (34.4%) |
11-20 mm1) | 6 (42.9%) | 8 (40.0%) | 12 (44.4%) | 26 (42.6%) |
>20 mm | 3 (21.4%) | 6 (30.0%) | 5 (18.5%) | 14 (23.0%) |
Lymph node involvement | 5 (35.7%) | 7 (35.0%) | 9 (33.3%) | 21 (34.4%) |
Total | 14 | 20 | 27 | 61 |
Tumor stage according to TNM | ||||
pT1 | 12 (85.7%) | 14 (70.0%) | 22 (81.5%) | 48 (78.7%) |
pT2 | 2 (14.3%) | 5 (25.0%) | 5 (18.5%) | 12 (19.7%) |
pT3 | 1 (5.0%) | 1 (1.6%) | ||
pN0 | 9 (64.3%) | 13 (65.0%) | 18 (66.7%) | 40 (65.6%) |
pN1 | 4 (28.6%) | 4 (20.0%) | 6 (22.2%) | 14 (23.0%) |
pN2 | 1 (7.1%) | 2 (10.0%) | 2 (7.4%) | 5 (8.2%) |
pN3 | 1 (5.0%) | 1 (3.7%) | 2 (3.3%) | |
M0 | 13 (92.9%) | 19 (95.0%) | 26 (96.3%) | 58 (95.1%) |
M1 | 1 (7.1%) | 1 (5.0%) | 1 (3.7%) | 3 (4.9%) |